Breaking News Instant updates and real-time market news.

KAMN

Kaman

$57.84 /

+0.345 (+0.60%)

19:24
03/20/19
03/20
19:24
03/20/19
19:24

Kaman exploring sale of distribution segment, Bloomberg says

Kaman is looking into a sale of its industrial distribution unit as it seeks to focus on its aerospace activities, Bloomberg reports, citing people familiar with the matter. The company is working with financial advisers to seek suitors for Kaman Distribution, which could fetch roughly $700M, including debt, the report notes.

  • 17

    Apr

KAMN Kaman
$57.84 /

+0.345 (+0.60%)

12/14/18
On The Fly: Top five analyst downgrades
12/14/18 JPMorgan
Kaman downgraded to Underweight from Neutral at JPMorgan
07/12/18 JPMorgan
Kaman initiated with a Neutral at JPMorgan

TODAY'S FREE FLY STORIES

Upgrade
Corporate Office Properties upgraded to Overweight from Neutral at JPMorgan » 04:46
07/02/20
07/02
04:46
07/02/20
04:46
OFC

Corporate Office Properties

$25.25 /

-0.07 (-0.28%)

JPMorgan analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OFC Corporate Office Properties
$25.25 /

-0.07 (-0.28%)

OFC Corporate Office Properties
$25.25 /

-0.07 (-0.28%)

05/04/20 SMBC Nikko
Corporate Office Properties upgraded to Outperform from Neutral at SMBC Nikko
04/06/20 BofA
Corporate Office Properties upgraded to Buy from Neutral at BofA
04/06/20 BofA
Corporate Office Properties upgraded to Buy from Neutral at BofA
02/04/20 Mizuho
Corporate Office Properties assumed with a Neutral at Mizuho
OFC Corporate Office Properties
$25.25 /

-0.07 (-0.28%)

Upgrade
Washington REIT upgraded to Neutral from Underweight at JPMorgan » 04:45
07/02/20
07/02
04:45
07/02/20
04:45
WRE

Washington REIT

$22.49 /

+0.31 (+1.40%)

JPMorgan analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRE Washington REIT
$22.49 /

+0.31 (+1.40%)

Upgrade
Assa Abloy upgraded to Buy from Hold at Deutsche Bank » 04:45
07/02/20
07/02
04:45
07/02/20
04:45
ASAZY

Assa Abloy

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASAZY Assa Abloy
$0.00 /

+ (+0.00%)

05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
04/30/20 Morgan Stanley
Assa Abloy price target raised to SEK 189 from SEK 178 at Morgan Stanley
04/21/20 Jefferies
Assa Abloy upgraded to Buy from Hold at Jefferies
04/09/20 Deutsche Bank
Assa Abloy price target lowered to SEK 175 from SEK 180 at Deutsche Bank
Upgrade
Seacoast Banking upgraded to Buy from Neutral at B. Riley FBR » 04:42
07/02/20
07/02
04:42
07/02/20
04:42
SBCF

Seacoast Banking

$19.27 /

-1.14 (-5.59%)

B. Riley FBR analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBCF Seacoast Banking
$19.27 /

-1.14 (-5.59%)

SBCF Seacoast Banking
$19.27 /

-1.14 (-5.59%)

06/04/20 B. Riley FBR
Seacoast Banking price target raised to $25 from $21 at B. Riley FBR
01/09/20 B. Riley FBR
Seacoast Banking upgraded to Buy from Neutral at B. Riley FBR
10/28/19 B. Riley FBR
Seacoast Banking downgraded to Neutral from Buy at B. Riley FBR
SBCF Seacoast Banking
$19.27 /

-1.14 (-5.59%)

Downgrade
Auto Trader Group downgraded to Add from Buy at Peel Hunt » 04:41
07/02/20
07/02
04:41
07/02/20
04:41
ATDRY

Auto Trader Group

$0.00 /

+ (+0.00%)

Peel Hunt analyst Malcolm…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATDRY Auto Trader Group
$0.00 /

+ (+0.00%)

04:40 Today Liberum
Auto Trader Group downgraded to Hold from Buy at Liberum
06/29/20 UBS
Auto Trader Group downgraded to Neutral from Buy at UBS
06/26/20 Barclays
Auto Trader Group price target raised to 490 GBp from 440 GBp at Barclays
06/02/20 Deutsche Bank
Auto Trader Group upgraded to Buy from Hold at Deutsche Bank
Downgrade
Auto Trader Group downgraded to Hold from Buy at Liberum » 04:40
07/02/20
07/02
04:40
07/02/20
04:40
ATDRY

Auto Trader Group

$0.00 /

+ (+0.00%)

Liberum analyst Harry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATDRY Auto Trader Group
$0.00 /

+ (+0.00%)

06/29/20 UBS
Auto Trader Group downgraded to Neutral from Buy at UBS
06/26/20 Barclays
Auto Trader Group price target raised to 490 GBp from 440 GBp at Barclays
06/02/20 Deutsche Bank
Auto Trader Group upgraded to Buy from Hold at Deutsche Bank
05/12/20 UBS
UBS maintains Buy on Auto Trader, says forecasts ahead of consensus
General news
FX Action: USD-CAD edged out a two-day peak » 04:15
07/02/20
07/02
04:15
07/02/20
04:15

FX Action: USD-CAD edged…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: The dollar and yen have traded moderately softer » 03:10
07/02/20
07/02
03:10
07/02/20
03:10

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Asian Market Update: » 02:00
07/02/20
07/02
02:00
07/02/20
02:00

Asian Market Update: The…

Asian Market Update: The 10-year Treasury yield is down -0.5 bp at 0.67%. Stock markets meanwhile got a boost from positive virus developments while U.S. data releases helped to ease worries over the impact of rising new virus cases in the U.S. Hong Kong shares outperformed after returning from a holiday, despite violent clashes after China unveiled the details of a new security law for the city. U.S. House of Representatives passed a bill imposing sanctions on banks that do business with Chinese officials involved in cracking down on pro-democracy protesters in Hong Kong and the issue could further sour relations between Washington and Beijing. Still, news that an early trial of an experimental shot from Pfizer Inc and BioNtech SE was safe and prompted the production of antibodies boosted sentiment. Topix and Nikkei gained 0.4% and 0.2% respectively. The Hang Seng jumped 1.6% and the CSI 300 lifted 1.3%, while the ASX rallied 1.6%. U.S. stock futures are also slightly higher as the focus shifts to the U.S. jobs report today. In FX markets USD-JPY traded little changed at 107.46. AUD and NZD gained. The front end WTI future meanwhile is trading at USD 39.76 per barrel.

General news
U.K. NFP preview: » 02:00
07/02/20
07/02
02:00
07/02/20
02:00

U.K. NFP preview:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Envision Solar 1.212M share Secondary priced at $8.25 » 21:41
07/01/20
07/01
21:41
07/01/20
21:41
EVSI

Envision Solar

$9.27 /

-0.66 (-6.65%)

Maxim acted as lead book…

Maxim acted as lead book running manager for the offering.

ShowHide Related Items >><<
EVSI Envision Solar
$9.27 /

-0.66 (-6.65%)

EVSI Envision Solar
$9.27 /

-0.66 (-6.65%)

03/03/20
LD Micro to hold a virtual conference
Syndicate
Document Security 1.03M share Spot Secondary priced at $6.25 » 21:01
07/01/20
07/01
21:01
07/01/20
21:01
DSS

Document Security

$8.07 /

-0.09 (-1.10%)

Aegis is acting as sole…

Aegis is acting as sole book running manager for the offering.

ShowHide Related Items >><<
DSS Document Security
$8.07 /

-0.09 (-1.10%)

DSS Document Security
$8.07 /

-0.09 (-1.10%)

06/24/20 Aegis
Document Security assumed with a Buy at Aegis
10/10/19 Aegis
Document Security initiated with a Buy rating at Aegis
DSS Document Security
$8.07 /

-0.09 (-1.10%)

  • 22
    May
  • 21
    Feb
DSS Document Security
$8.07 /

-0.09 (-1.10%)

Hot Stocks
SPDR Gold Shares holdings rise to 1,182.11MT from 1,178.90M » 20:18
07/01/20
07/01
20:18
07/01/20
20:18
GLD

SPDR Gold Shares

$166.58 /

-0.77 (-0.46%)

This is the highest level…

This is the highest level of holdings since April of 2013.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$166.58 /

-0.77 (-0.46%)

GLD SPDR Gold Shares
$166.58 /

-0.77 (-0.46%)

GLD SPDR Gold Shares
$166.58 /

-0.77 (-0.46%)

GLD SPDR Gold Shares
$166.58 /

-0.77 (-0.46%)

Downgrade
Heineken downgraded to Neutral from Overweight at JPMorgan » 19:44
07/01/20
07/01
19:44
07/01/20
19:44
HEINY

Heineken

$0.00 /

+ (+0.00%)

JPMorgan analyst Celine…

JPMorgan analyst Celine Pannuti downgraded Heineken to Neutral from Overweight with an EUR 80 price target.

ShowHide Related Items >><<
HEINY Heineken
$0.00 /

+ (+0.00%)

HEINY Heineken
$0.00 /

+ (+0.00%)

06/15/20 Credit Suisse
Heineken upgraded to Outperform from Neutral at Credit Suisse
06/12/20 Credit Suisse
Heineken upgraded to Outperform from Neutral at Credit Suisse
06/04/20 Societe Generale
Heineken price target raised to EUR 92 from EUR 91 at Societe Generale
04/24/20 RBC Capital
Heineken price target lowered to EUR 72 from EUR 74 at RBC Capital
HEINY Heineken
$0.00 /

+ (+0.00%)

Periodicals
House passes bill to extend PPP, WSJ reports » 19:06
07/01/20
07/01
19:06
07/01/20
19:06
SPY

SPDR S&P 500 ETF Trust

$310.56 /

+2.11 (+0.68%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The U.S. House of…

The U.S. House of Representatives passed legislation extending the timeline into next month for small businesses to apply for the Paycheck Protection Program, building on a surprise vote in the Senate the day before, the Wall Street Journal's Natalie Andrews reports. The deadline was Tuesday for the PPP, and as of now roughly $130B of the original $670B set aside for small businesses has remained unclaimed, Andrews says. Reference Link

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$310.56 /

+2.11 (+0.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

On The Fly
Fly Intel: After-Hours Movers » 18:55
07/01/20
07/01
18:55
07/01/20
18:55
VERO

Venus Concept

$3.21 /

-0.275 (-7.89%)

, FEIM

Frequency Electronics

$9.15 /

+ (+0.00%)

, NUS

Nu Skin

$38.48 /

+0.35 (+0.92%)

, FORM

FormFactor

$29.34 /

+0.01 (+0.03%)

, AXNX

Axonics

$36.38 /

+1.26 (+3.59%)

, LDOS

Leidos

$93.34 /

-0.39 (-0.42%)

, CULP

Culp, Inc.

$10.03 /

+1.375 (+15.89%)

, BLFS

BioLife Solutions

$16.09 /

-0.22 (-1.35%)

, PLYA

Playa Hotels & Resorts

$3.66 /

+0.03 (+0.83%)

, AKRO

Akero Therapeutics

$33.49 /

+8.64 (+34.77%)

, MCD

McDonald's

$184.50 /

+0.15 (+0.08%)

, FIZZ

National Beverage

$63.51 /

+2.34 (+3.83%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
VERO Venus Concept
$3.21 /

-0.275 (-7.89%)

PLYA Playa Hotels & Resorts
$3.66 /

+0.03 (+0.83%)

NUS Nu Skin
$38.48 /

+0.35 (+0.92%)

MCD McDonald's
$184.50 /

+0.15 (+0.08%)

LDOS Leidos
$93.34 /

-0.39 (-0.42%)

FORM FormFactor
$29.34 /

+0.01 (+0.03%)

FEIM Frequency Electronics
$9.15 /

+ (+0.00%)

CULP Culp, Inc.
$10.03 /

+1.375 (+15.89%)

BLFS BioLife Solutions
$16.09 /

-0.22 (-1.35%)

AXNX Axonics
$36.38 /

+1.26 (+3.59%)

AKRO Akero Therapeutics
$33.49 /

+8.64 (+34.77%)

VERO Venus Concept
$3.21 /

-0.275 (-7.89%)

03/31/20
Fly Intel: Top five analyst downgrades
03/31/20 Oppenheimer
Venus Concept downgraded to Perform at Oppenheimer as COVID-19 clouds outlook
03/31/20 Oppenheimer
Venus Concept downgraded to Perform from Outperform at Oppenheimer
01/09/20 Oppenheimer
Oppenheimer says has 'fundamentally positive' stance on Venus Concept
FEIM Frequency Electronics
$9.15 /

+ (+0.00%)

NUS Nu Skin
$38.48 /

+0.35 (+0.92%)

06/24/20 Citi
Nu Skin price target raised to $41 from $29 at Citi
05/07/20 Deutsche Bank
Nu Skin price target raised to $35 from $28 at Deutsche Bank
03/09/20 Deutsche Bank
Nu Skin downgraded to Hold from Buy at Deutsche Bank
02/13/20 DA Davidson
Nu Skin price target lowered to $35 from $42 at DA Davidson
FORM FormFactor
$29.34 /

+0.01 (+0.03%)

06/18/20 B. Riley FBR
FormFactor price target raised to $36 from $30 at B. Riley FBR
06/15/20 Stifel
FormFactor upgraded to Buy from Hold at Stifel
06/01/20 DA Davidson
FormFactor upgraded to Buy from Neutral at DA Davidson
06/01/20 DA Davidson
FormFactor upgraded to Buy from Neutral at DA Davidson
AXNX Axonics
$36.38 /

+1.26 (+3.59%)

04/21/20 Piper Sandler
Axonics price target lowered to $44 from $48 at Piper Sandler
04/14/20 Piper Sandler
Axonics next-gen INS not compatible with InterStim II leads, says Piper Sandler
04/08/20 Wells Fargo
Axonics price target lowered to $35 from $47 at Wells Fargo
03/05/20 SunTrust
Axonics price target raised to $48 from $38 at SunTrust
LDOS Leidos
$93.34 /

-0.39 (-0.42%)

06/11/20
Fly Intel: Top five analyst initiations
06/11/20 Baird
Baird starts Leidos at Outperform, sees growth poised to ramp next year
06/10/20 Baird
Leidos initiated with an Outperform at Baird
05/07/20
Fly Intel: Top five analyst initiations
CULP Culp, Inc.
$10.03 /

+1.375 (+15.89%)

05/28/20 Stifel
Culp upgraded to Buy from Hold at Stifel
02/19/20
Fly Intel: Top five analyst downgrades
02/19/20 Stifel
Culp, Inc. downgraded to Hold from Buy at Stifel
09/09/19 Raymond James
Culp, Inc. price target lowered to $18 from $22 at Raymond James
BLFS BioLife Solutions
$16.09 /

-0.22 (-1.35%)

05/15/20 Stephens
BioLife Solutions price target raised to $24 after 'strong' Q1 beat at Stephens
03/23/20 H.C. Wainwright
BioLife Solutions price target lowered to $17 from $26 at H.C. Wainwright
02/24/20 Lake Street
BioLife Solutions initiated with a Buy at Lake Street
02/19/20 Benchmark
BioLife Solutions initiated with a Buy at Benchmark
PLYA Playa Hotels & Resorts
$3.66 /

+0.03 (+0.83%)

04/29/20 SunTrust
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
04/29/20 SunTrust
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
04/07/20 Citi
Playa Hotels & Resorts downgraded to Sell from Neutral at Citi
04/03/20 Deutsche Bank
Playa Hotels & Resorts price target lowered to $7 from $11 at Deutsche Bank
AKRO Akero Therapeutics
$33.49 /

+8.64 (+34.77%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
MCD McDonald's
$184.50 /

+0.15 (+0.08%)

06/24/20 BMO Capital
McDonald's price target raised to $220 from $215 at BMO Capital
06/24/20 JPMorgan
McDonald's price target raised to $204 from $180 at JPMorgan
06/17/20 Morgan Stanley
McDonald's price target raised to $200 from $189 at Morgan Stanley
06/17/20 SunTrust
McDonald's price target raised to $208 from $195 at SunTrust
FIZZ National Beverage
$63.51 /

+2.34 (+3.83%)

05/18/20 Guggenheim
National Beverage price target raised to $38 from $34 at Guggenheim
11/18/19 Guggenheim
Coca-Cola's 'AHA' likely to take shelf space from LaCroix, says Guggenheim
11/11/19 Jefferies
National Beverage estimates and price target lowered at Jefferies
VERO Venus Concept
$3.21 /

-0.275 (-7.89%)

PLYA Playa Hotels & Resorts
$3.66 /

+0.03 (+0.83%)

NUS Nu Skin
$38.48 /

+0.35 (+0.92%)

MCD McDonald's
$184.50 /

+0.15 (+0.08%)

LDOS Leidos
$93.34 /

-0.39 (-0.42%)

FORM FormFactor
$29.34 /

+0.01 (+0.03%)

FIZZ National Beverage
$63.51 /

+2.34 (+3.83%)

CULP Culp, Inc.
$10.03 /

+1.375 (+15.89%)

BLFS BioLife Solutions
$16.09 /

-0.22 (-1.35%)

AXNX Axonics
$36.38 /

+1.26 (+3.59%)

AKRO Akero Therapeutics
$33.49 /

+8.64 (+34.77%)

  • 02
    Jul
  • 08
    May
  • 20
    Nov
MCD McDonald's
$184.50 /

+0.15 (+0.08%)

LDOS Leidos
$93.34 /

-0.39 (-0.42%)

PLYA Playa Hotels & Resorts
$3.66 /

+0.03 (+0.83%)

NUS Nu Skin
$38.48 /

+0.35 (+0.92%)

MCD McDonald's
$184.50 /

+0.15 (+0.08%)

LDOS Leidos
$93.34 /

-0.39 (-0.42%)

BLFS BioLife Solutions
$16.09 /

-0.22 (-1.35%)

AXNX Axonics
$36.38 /

+1.26 (+3.59%)

AKRO Akero Therapeutics
$33.49 /

+8.64 (+34.77%)

MCD McDonald's
$184.50 /

+0.15 (+0.08%)

FIZZ National Beverage
$63.51 /

+2.34 (+3.83%)

AKRO Akero Therapeutics
$33.49 /

+8.64 (+34.77%)

Syndicate
Lemonade 11M share IPO priced at $29.00 » 18:49
07/01/20
07/01
18:49
07/01/20
18:49
LMND

Lemonade

$0.00 /

+ (+0.00%)

The deal priced above the…

The deal priced above the $26.00-$28.00 range. Goldman Sachs, Morgan Stanley, Allen & Co. and Barclays are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 02
    Jul
Hot Stocks
Williams-Sonoma CEO: Seeing strong growth in baby, dorm business » 18:34
07/01/20
07/01
18:34
07/01/20
18:34
WSM

Williams-Sonoma

$84.79 /

+2.905 (+3.55%)

In an interview on…

In an interview on CNBC's Mad Money, Laura Alber said there are a lot of secular trends supportive to the company's business. She expects e-commerce to be a growth driver. According to Alber, stores are a competitive advantage, but not as many are needed as previously.

ShowHide Related Items >><<
WSM Williams-Sonoma
$84.79 /

+2.905 (+3.55%)

WSM Williams-Sonoma
$84.79 /

+2.905 (+3.55%)

06/18/20
Fly Intel: Top five analyst initiations
06/18/20 Wells Fargo
Williams-Sonoma initiated with an Equal Weight at Wells Fargo
06/05/20 Argus
Williams-Sonoma price target raised to $95 from $80 at Argus
06/01/20 Loop Capital
Williams-Sonoma price target raised to $80 from $40 at Loop Capital
WSM Williams-Sonoma
$84.79 /

+2.905 (+3.55%)

WSM Williams-Sonoma
$84.79 /

+2.905 (+3.55%)

WSM Williams-Sonoma
$84.79 /

+2.905 (+3.55%)

WSM Williams-Sonoma
$84.79 /

+2.905 (+3.55%)

Hot Stocks
FAA says Boeing completes 737 MAX certification flight tests » 18:33
07/01/20
07/01
18:33
07/01/20
18:33
BA

Boeing

$180.33 /

-3.05 (-1.66%)

The FAA and Boeing…

The FAA and Boeing completed the certification flight tests on the Boeing 737 MAX. During three days of testing this week, FAA pilots and engineers evaluated Boeing's proposed changes in connection with the automated flight control system on the aircraft. While completion of the flights is an important milestone, a number of key tasks remain, including evaluating the data gathered during these flights. The agency is following a deliberate process and will take the time it needs to thoroughly review Boeing's work. "We will lift the grounding order only after FAA safety experts are satisfied that the aircraft meets certification standards," the FAA said. The remaining tasks include JOEB validation and FSB review, the final FSB report, final design documentation, a TAB report, CANIC & AD responses, a rescinding of the grounding order, certificates of airworthiness, and operator training programs.

ShowHide Related Items >><<
BA Boeing
$180.33 /

-3.05 (-1.66%)

BA Boeing
$180.33 /

-3.05 (-1.66%)

06/26/20
Fly Intel: Top five analyst downgrades
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
06/26/20 Bernstein
Boeing downgraded to Market Perform from Outperform at Bernstein
06/25/20
Fly Intel: Top five analyst downgrades
BA Boeing
$180.33 /

-3.05 (-1.66%)

BA Boeing
$180.33 /

-3.05 (-1.66%)

BA Boeing
$180.33 /

-3.05 (-1.66%)

BA Boeing
$180.33 /

-3.05 (-1.66%)

Hot Stocks
PG&E emerges from Chapter 11 » 18:31
07/01/20
07/01
18:31
07/01/20
18:31
PCG

PG&E

$9.03 /

+0.16 (+1.80%)

PG&E and Pacific Gas…

PG&E and Pacific Gas and Electric Company announced that PG&E has emerged from Chapter 11, successfully completing its restructuring process and implementing PG&E's Plan of Reorganization that was confirmed by the United States Bankruptcy Court on June 20, 2020. Pursuant to the Plan-which was confirmed by the Bankruptcy Court, approved by the California Public Utilities Commission, and accepted by more than 85% of fire victims who cast votes on it-all negotiated settlements of wildfire claims have been implemented as provided in the Plan. In accordance with the Plan, PG&E has now funded the Fire Victim Trust established to satisfy the claims of individual wildfire victims and others. The Fire Victim Trust funding schedule is as follows: $5.4 billion in cash on the Plan effective date, which was July 1, 2020; an additional $1.35 billion in cash in two installments in 2021 and 2022; PG&E Corporation common stock on the Plan effective date representing 22.19% of the outstanding common stock as of such date ; plus certain other rights. A $700 million payment scheduled for 2022 will be accelerated if the CPUC approves the rate-neutral securitization application PG&E filed on April 30, 2020.

ShowHide Related Items >><<
PCG PG&E
$9.03 /

+0.16 (+1.80%)

PCG PG&E
$9.03 /

+0.16 (+1.80%)

06/24/20 Vertical Research
PG&E initiated with a Buy at Vertical Research
06/23/20 Seaport Global
PG&E initiated with a Neutral at Seaport Global
06/10/20 Barclays
PG&E price target raised to $16 from $15 at Barclays
06/09/20 Morgan Stanley
PG&E updated financing plan offers less downside risk, says Morgan Stanley
PCG PG&E
$9.03 /

+0.16 (+1.80%)

  • 26
    Jun
PCG PG&E
$9.03 /

+0.16 (+1.80%)

PCG PG&E
$9.03 /

+0.16 (+1.80%)

PCG PG&E
$9.03 /

+0.16 (+1.80%)

Hot Stocks
Novartis to pay $678M to settle DOJ fraud suit » 18:30
07/01/20
07/01
18:30
07/01/20
18:30
NVS

Novartis

$87.85 /

+0.445 (+0.51%)

Audrey Strauss, the…

Audrey Strauss, the Acting United States Attorney for the Southern District of New York, announced that the United States has settled a civil fraud lawsuit against Novartis Pharmaceuticals, part of Swiss drug manufacturer Novartis International AG, alleging that Novartis violated the federal False Claims Act and Anti-Kickback Statute by providing doctors with cash payments, recreational outings, lavish meals, and expensive alcohol to induce them to prescribe Novartis cardiovascular and diabetes drugs reimbursed by federal healthcare programs. Specifically, the Government alleged that Novartis organized tens of thousands of sham educational events at high-end restaurants and other venues, paid exorbitant speaker fees to doctors who gave no meaningful presentations, and provided expensive meals and alcohol to doctor attendees and their guests. When those doctors then prescribed Novartis's cardiovascular and diabetes drugs, federal healthcare programs paid hundreds of millions of dollars in reimbursements for these tainted prescriptions. As part of the settlement, approved today by U.S. District Judge Paul E. Gardephe, Novartis will pay the United States and various States a total of $678M. Novartis also made extensive factual admissions in the settlement and agreed to strict limitations on any future speaker programs, including reductions to the amount it may spend on such programs. Acting U.S. Attorney Audrey Strauss said: "For more than a decade, Novartis spent hundreds of millions of dollars on so-called speaker programs, including speaking fees, exorbitant meals, and top-shelf alcohol that were nothing more than bribes to get doctors across the country to prescribe Novartis's drugs. Giving these cash payments and other lavish goodies interferes with the duty of doctors to choose the best treatment for their patients and increases drug costs for everyone. This Office will continue to be vigilant in cracking down on kickbacks, however they may be dressed up, throughout the pharmaceutical industry." Reference Link

ShowHide Related Items >><<
NVS Novartis
$87.85 /

+0.445 (+0.51%)

NVS Novartis
$87.85 /

+0.445 (+0.51%)

07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
NVS Novartis
$87.85 /

+0.445 (+0.51%)

NVS Novartis
$87.85 /

+0.445 (+0.51%)

NVS Novartis
$87.85 /

+0.445 (+0.51%)

NVS Novartis
$87.85 /

+0.445 (+0.51%)

Hot Stocks
General Mills CEO: Our business accelerated over the past three months » 18:23
07/01/20
07/01
18:23
07/01/20
18:23
GIS

General Mills

$60.43 /

-1.205 (-1.96%)

In an interview on…

In an interview on CNBC's Mad Money, Jeff Harmening said the company had a good year going into the pandemic. He is "most proud" of the leverage ratio and cash flow, which is even better than earnings. Blue Buffalo is "everything we thought it would be," he said. The company's international business is strong, according to Harmening.

ShowHide Related Items >><<
GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

06/29/20 Jefferies
Jefferies staying sidelined on General Mills ahead of earnings
06/11/20 Bernstein
General Mills downgraded to Underperform from Market Perform at Bernstein
05/21/20 Jefferies
General Mills price target raised to $61 from $56 at Jefferies
05/19/20 Piper Sandler
General Mills price target raised to $71 from $67 at Piper Sandler
GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

GIS General Mills
$60.43 /

-1.205 (-1.96%)

Periodicals
EU in talks to reserve doses of Gilead's remdesivir, FT reports » 18:20
07/01/20
07/01
18:20
07/01/20
18:20
GILD

Gilead

$76.03 /

-0.93 (-1.21%)

The European Commission…

The European Commission in discussions with Gilead to reserve doses of its remdesivir drug to combat COVID-19 after the U.S. said it had purchased much of the global supply, the Financial Times' Michael Peel and Donato Paolo Mancini report. Stella Kyriakides, health commissioner for the EU, has held a series of talks with the pharma company, including over its production capacity, the authors say. "Commissioner Kyriakides has been in multiple discussions with the manufacturer, Gilead, including on their production capacity," the commission said. "The commission is also currently in negotiations with Gilead to reserve doses of remdesivir for EU member states." Reference Link

ShowHide Related Items >><<
GILD Gilead
$76.03 /

-0.93 (-1.21%)

GILD Gilead
$76.03 /

-0.93 (-1.21%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
GILD Gilead
$76.03 /

-0.93 (-1.21%)

GILD Gilead
$76.03 /

-0.93 (-1.21%)

GILD Gilead
$76.03 /

-0.93 (-1.21%)

GILD Gilead
$76.03 /

-0.93 (-1.21%)

Syndicate
Envision Solar offers to sell common stock, no amount given » 18:20
07/01/20
07/01
18:20
07/01/20
18:20
EVSI

Envision Solar

$9.27 /

-0.66 (-6.65%)

Maxim Group LLC is acting…

Maxim Group LLC is acting as the sole book-running manager for the offering.

ShowHide Related Items >><<
EVSI Envision Solar
$9.27 /

-0.66 (-6.65%)

EVSI Envision Solar
$9.27 /

-0.66 (-6.65%)

03/03/20
LD Micro to hold a virtual conference
Periodicals
U.K.'s CMA takes aim at Apple-Google search engine deal, Reuters says » 18:15
07/01/20
07/01
18:15
07/01/20
18:15
AAPL

Apple

$364.11 /

-0.35 (-0.10%)

, GOOG

Alphabet

$1,437.90 /

+24.39 (+1.73%)

, GOOGL

Alphabet Class A

$1,443.21 /

+25.29 (+1.78%)

, MSFT

Microsoft

$204.62 /

+1.11 (+0.55%)

, VZ

Verizon

$54.67 /

-0.4 (-0.73%)

The U.K. Competition and…

The U.K. Competition and Markets Authority said that payments by Alphabet's (GOOG) Google to Apple (AAPL) to be the default search engine on the Safari web browser establish "a significant barrier to entry and expansion" for Google's competitors in the search engine market, Reuters' Stephen Nellis reports. According to the report from CMA, Apple received the "substantial majority" of the GBP1.2B that Google paid to be the default search engine on a host of devices in the U.K. in 2019, Nellis says. The markets regulators said the arrangements between the two companies create "a significant barrier to entry and expansion" for search rivals such as Microsoft's (MSFT) Bing, Verizon's (VZ) Yahoo, and independent search engine DuckDuckGo, the author notes. Reference Link

ShowHide Related Items >><<
VZ Verizon
$54.67 /

-0.4 (-0.73%)

MSFT Microsoft
$204.62 /

+1.11 (+0.55%)

GOOG Alphabet
$1,437.90 /

+24.39 (+1.73%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

06/26/20 Evercore ISI
Evercore upgrades Broadcom to Outperform, sees Apple sales driving upside
06/25/20 Wedbush
Wedbush boosts Apple target to $425, sees $2 trillion valuation in 2021
06/24/20 BMO Capital
Criteo downgraded to Market Perform from Outperform at BMO Capital
06/23/20 Baird
Apple price target raised to $390 from $320 at Baird
GOOG Alphabet
$1,437.90 /

+24.39 (+1.73%)

06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
06/25/20 Baird
Alphabet price target raised to $1,650 from $1,500 at Baird
06/24/20 Bernstein
Potential spinoff would be largely positive for VMware, says Bernstein
06/24/20 Goldman Sachs
Alphabet price target raised to $1,775 from $1,425 at Goldman Sachs
GOOGL Alphabet Class A
$1,443.21 /

+25.29 (+1.78%)

MSFT Microsoft
$204.62 /

+1.11 (+0.55%)

06/29/20 JMP Securities
ZoomInfo initiated with a Market Perform at JMP Securities
06/24/20 Baird
Ping Identity initiated with a Neutral at Baird
06/24/20 Argus
Microsoft price target raised to $235 from $200 at Argus
VZ Verizon
$54.67 /

-0.4 (-0.73%)

06/11/20 Wells Fargo
T-Mobile price target raised to $120 from $110 at Wells Fargo
05/20/20 KeyBanc
T-Mobile price target raised to $126 from $104 at KeyBanc
05/04/20 Needham
Ceragon longer-term news continues to improve, says Needham
04/28/20 SunTrust
Verizon price target raised to $65 from $60 at SunTrust
VZ Verizon
$54.67 /

-0.4 (-0.73%)

MSFT Microsoft
$204.62 /

+1.11 (+0.55%)

GOOG Alphabet
$1,437.90 /

+24.39 (+1.73%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

VZ Verizon
$54.67 /

-0.4 (-0.73%)

MSFT Microsoft
$204.62 /

+1.11 (+0.55%)

GOOGL Alphabet Class A
$1,443.21 /

+25.29 (+1.78%)

GOOG Alphabet
$1,437.90 /

+24.39 (+1.73%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

VZ Verizon
$54.67 /

-0.4 (-0.73%)

MSFT Microsoft
$204.62 /

+1.11 (+0.55%)

GOOG Alphabet
$1,437.90 /

+24.39 (+1.73%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

VZ Verizon
$54.67 /

-0.4 (-0.73%)

MSFT Microsoft
$204.62 /

+1.11 (+0.55%)

GOOGL Alphabet Class A
$1,443.21 /

+25.29 (+1.78%)

GOOG Alphabet
$1,437.90 /

+24.39 (+1.73%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

GOOG Alphabet
$1,437.90 /

+24.39 (+1.73%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.